Ali Aminian, ESC 2021 – Obesity and COVID-19
Dr Ali Aminian (Director, Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH, USA) kindly shared his thoughts on the association between obesity and COVID-19 and the results of his study on the association of prior metabolic surgery and bariatric surgery with COVID-19 severity from the virtual ESC Congress 2021. Questions What have we learned about […]
Darryl Leong, ESC 2021 – Cardiometabolic Risk Factors and COVID-19
Dr Darryl Leong (Cardiologist, The Population Health Research Institute, McMaster University, Hamilton, ON, Canada) kindly shared his thoughts on the association between cardiometabolic risk factors and COVID-19 outcomes from the virtual ESC Congress 2021. Questions What has recent data taught us about the association between cardiometabolic risk factors and COVID-19 outcomes? (0.15) On the basis […]
Diana Bonderman, ESC 2021 – the DYNAMIC Study
Prof. Diana Bonderman (Cardiologist, Medical University of Vienna, Vienna, Austria) kindly shared her thoughts on the current challenges in the treatment of pulmonary hypertension and heart failure with preserved ejection fraction, the mechanism and use of riociguat, and the DYNAMIC study (NCT02744339) from from the virtual ESC Congress 2021. Questions What are the challenges in […]
Gilles Montalescot, ESC 2021 – the QUORUM Clinical Study
Prof. Gilles Montalescot (Professor, Pitié-Salpêtrière Hospital, Paris, France) kindly shared his thoughts on the difficulty of treating heart failure after acute myocardial infarction, the use of firibastat and the QUORUM clinical study (NCT03715998) from the virtual ESC Congress 2021. Questions Why does heart failure after acute myocardial infarction remain so challenging to treat? (0.19) Could […]
COVID-19 and Cardiac Arrhythmias
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):33-39 DOI: https://doi.org/10.17925/EJAE.2021.7.1.33
The current outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has developed into a worldwide pandemic affecting millions of lives in one way or another.1 Over the period of 1 year since the disease was first reported from Wuhan, China,2 COVID-19 has infected over 50 million patients and resulted […]
Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease
Heart International. 2021;15(1):14-19 DOI: https://doi.org/10.17925/HI.2021.15.1.14
Peripheral artery disease (PAD) is a severe manifestation of systemic atherosclerotic disease that commonly refers to lower-extremity arterial involvement. The global burden of PAD is estimated to involve over 200 million patients, with prevalence increasing by 24% over the past decade.1 In contrast to myocardial infarction and stroke, which are declining in the USA, the […]
Dual Antiplatelet Therapy in Patients with High Cardiovascular Risk
Heart International. 2021;15(1):26-36 DOI: https://doi.org/10.17925/HI.2021.15.1.26
Coronary artery disease (CAD) is encountered on a daily basis in the field of medicine. Between 2009 and 2012, the global prevalence of CAD was 154 million, based on data from the Global Burden of Disease study; for the same period in the USA, it was approximately 15.5 million, based on data collected by the […]
The Role of Rilonacept in Recurrent Pericarditis
Heart International. 2021;15(1):20-25 DOI: https://doi.org/10.17925/HI.2021.15.1.20
Pericarditis is the most common form of pericardial disease, with an incidence of 27.7 cases per 100,000 population per year.1 Approximately 15–30% of patients with acute pericarditis will have a first recurrence within 18 months despite optimal medical therapy. Half of these patients will fail to achieve complete remission and will continue to have recurrent […]
Click here to view more medical education and communication. This content is sponsored by the pharmaceutical industry and developed by TMC.
Comprehensive Review of Complete Versus Culprit-only Revascularization for Multivessel Disease in ST-segment Elevation Myocardial Infarction
Heart International. 2021;15(1):54–9 DOI: https://doi.org/10.17925/HI.2021.15.1.54
Multivessel disease is common amongst patients presenting with ST-segment elevation myocardial infarction (STEMI). Previous studies have shown that up to 40–65% of patients presenting with STEMI have multivessel disease.1 Pooled analyses of STEMI trials from the fibrinolytic and percutaneous coronary intervention (PCI) eras reveal that the presence of obstructive multivessel disease has been associated with […]
Foreword – European Journal of Arrhythmia & Electrophysiology. 2021;7(1):1
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):1
Welcome to a new issue of the European Journal of Arrhythmia & Electrophysiology. As the ongoing coronavirus disease 2019 (COVID-19) pandemic continues to provide unprecedented challenges for electrophysiologists and other healthcare providers who manage arrhythmias, we hope you find these topical articles interesting and useful. We begin with an editorial from Professor Hugh Calkins and […]
Pathogenesis of Atrial Fibrillation in Patients with Diabetes Mellitus: Impact on Ablation and Disease Recurrence
European Journal of Arrhythmia & Electrophysiology. 2021;7(1):26-32 DOI: https://doi.org/10.17925/EJAE.2021.7.1.26
Atrial fibrillation (AF) is the most common cardiac arrhythmia observed in clinical practice worldwide.1 The incidence of AF is around 0.1% in individuals under 55 years old and 9% in those aged over 80.2 The global prevalence of AF is estimated to be around 44 million, which is approximately 0.5% of the total world population.3,4 Therefore, […]
Foreword: Heart International. 2021;15(1):1
Welcome to the summer 2021 edition of Heart International. This issue contains 9 informative review articles on a range of topics which we hope will be of interest to all cardiovascular practitioners, regardless of subspecialism. We begin with a review by Chu and Gupta, who explore the use of etripamil nasal spray, a novel preparation […]
Want To Know More About Our Journals?
Taking a balanced and practical view of the current clinical landscape in Cardio is at the heart of touchCARDIO and the journals we produce.
The European Journal of Arrhythmia & Electrophysiology and Heart International are double-blind peer reviewed by at least two independent experts in the field to ensure articles are balanced, objective and relevant to the day-to-day clinical setting.
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!